Hemorrhagic transformation after intracranial stenting for acute stroke: Clinical insights from the RESISTANT registry

View at publisher Summarise with VIRAT
Authors: Marta Olivé‐Gadea, Adnan Mujanović, Johannes Kaesmacher, Serdar Geyik, Songül Şenadım, Amedeo Cervo, Andrea Salcuni, Mariangela Piano, Manuel Moreu, Alfonso López‐Frías, Ameer E Hassan, Samantha Miller
+64 more Francesco Diana, Elena Zapata‐Arriaza, Asier de Albóniga-Chindurza, Mauro Bergui, Stefano Molinaro, João André Sousa, Fábio Gomes, João Sargento‐Freitas, Andrea Maria Alexandre, Alessandro Pedicelli, Jérémy Hofmeister, Paolo Machi, Michail Panagiotis Giannakakis, Luca Scarcia, Erwah Kalsoum, José Manuel Amorim, Torcato Meira, Santiago Ortega‐Gutiérrez, Leonardo Cruz‐Criollo, Leonardo Renieri, Francesco Capasso, Daniele Giuseppe Romano, Eduardo Bárcena-Ruiz, David Seoane, Mohamad K. Abdalkader, Piers Klein, Thanh Ngoc Nguyen, Catarina Perry da Câmara, Isabel Fragata, Dileep R. Yavagal, Aarón Rodríguez-Calienes, Jude Hassan Charles, José Rodríguez Castro, Pedro Vega, Atilla Özcan Özdemir, Zehra Uysal Kocabaş, Stanislas Smajda, Sadiq Al Salman, Jane Khalife, Tudor G. Jovin, Francesco Biraschi, Francesca Ricchetti, Paola Castro, Luís Albuquerque, Adnan Hussain Siddiqui, Vinay Jaikumar, Pedro Navía, Nikolaos Ntoulias, Marios‐Nikos Psychogios, Mariano Velo, Joaquín Zamarro, Gonzalo de Paco, Yazan K Ashouri, Mohammad AlMajali, Juan Francisco Arenillas, Alicia Sierra‐Gómez, Michele Romoli, João Pedro Marto, Shadi R. Yaghi, Jan Gralla, Urs Fischer, Marc Ribó, Alejandro Tomasello, Manuel Requena
Cited by: 0
References: 22

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND AND AIM: Acute intracranial stenting is increasingly used as a rescue strategy during endovascular treatment for large vessel occlusion strokes. Limited data exist regarding the risk, clinical relevance, and optimal management of hemorrhagic transformation (HT) in this context. We aimed to evaluate the incidence, predictors, outcomes, and post-interventional antiplatelet management of HT in an international multicentric registry. METHODS: We analyzed data from the RESISTANT registry, including patients who underwent emergent intracranial stenting for acute stroke between 2016 and 2023. Two complementary analyses were performed: (1) characterization of HT subtypes and associated outcomes (NIHSS at discharge, mortality, and mRS at discharge and 90 days) and (2) evaluation of antiplatelet management after Heidelberg class-1 HT detection and its impact on stent occlusion, hemorrhage progression, in-hospital mortality, and 90-day mRS. RESULTS: Among 809 patients included, 177 (22%) experienced HT, of which 63 (8%) were symptomatic intracranial hemorrhage. Parenchymal hematomas (PH-1 and PH-2) and HI-2 were associated with worse functional outcomes and higher mortality. In the post-HT management cohort (n = 117), use of a high-intensity antiplatelet regimen (dual oral antiplatelet or any intravenous agent) was associated with lower risk of stent occlusion (adjusted risk ratio (aOR) = 0.21 [0.05-0.86]) and in-hospital mortality (aOR = 0.08 [0.01-0.50]) without increased hemorrhagic progression (0.52 [0.09-3.07]). CONCLUSION: HT remains a relevant complication after emergent intracranial stenting, particularly in patients with parenchymal hematoma. High-intensity antiplatelet therapy appears safe in select HT subtypes and was linked to reduced occlusion and mortality.

Fields of Study & Subjects

Acute Ischemic Stroke Management Intracranial Aneurysms: Treatment and Complications Intracerebral and Subarachnoid Hemorrhage Research

Publication details

Journal / source
International Journal of Stroke
Pages
17474930261440598–17474930261440598
Publication date
27 March 2026
Language
EN